, , , ,

J&J, U.S. states settle hip implant claims for $120 million

Johnson & Johnson and its DePuy Orthopaedics unit have agreed to pay $120 million to resolve deceptive marketing claims by several U.S. states over the company's metal-on-metal hip implants.
, , , ,

Medical News Today: How much omega-3 should you get each day?

The amount of omega-3 a person needs each day depends on their age and sex. People with certain health conditions, including heart disease, depression, and cancer, may benefit from taking extra omega-3. Learn more about how much omega-3 to take each day here.
, , , ,

Elderly who don’t want dialysis often pressured to get it

(Reuters Health) - Doctors tend to steer elderly people with failing kidneys toward dialysis even when patients say they'd rather avoid such treatments, a new study finds. And when patients decline dialysis, which wouldn't buy much more time for a frail, elderly patient, doctors often try to convince them to change their minds, the study shows.
, , , ,

Medical News Today: Alzheimer’s blood test detects brain damage years before symptoms

Testing blood levels of a protein that brain cells leak when faulty or dying detected people with Alzheimer's disease years before their symptoms emerged.
, , , ,

Amateur rock climbers often lack skills to save themselves

(Reuters Health) - - Most hobbyist rock climbers lack the basic rescue skills needed to save themselves in dangerous situations, a study suggests.
, , , ,

Medical News Today: How your immune system uses chaos to prevent disease

New research finds that chaotic swings in the concentration of a certain protein is key for regulating our immune response and preventing chronic disease.
, , , ,

U.S. top court rejects Helsinn over anti-nausea drug patent in win for Teva

The U.S. Supreme Court on Tuesday refused to revive Swiss drug company Helsinn Healthcare S.A.'s patent on the lucrative anti-nausea drug Aloxi in a victory for Teva Pharmaceutical Industries, which launched a generic version of it last year.
, , , ,

U.S. top court rejects Helsinn over anti-nausea drug patent in win for Teva

The U.S. Supreme Court on Tuesday refused to revive Swiss drug company Helsinn Healthcare S.A.'s patent on the lucrative anti-nausea drug Aloxi in a victory for Teva Pharmaceutical Industries, which launched a generic version of it last year.
, , , ,

Medical News Today: ‘Reprogramming’ immune cells to attack cancer tumors

Macrophages, the immune cells that 'eat' pathogens and cell debris, are often ineffective against cancer cells. How can we co-opt them to attack tumors?
, , , ,

U.S. insulin costs per patient nearly doubled from 2012 to 2016: study

The cost of insulin for treating type 1 diabetes in the United States nearly doubled over a five-year period, underscoring a national outcry over rising drug prices, according to a new analysis shared with Reuters.